Dr. Vidya Avinash Arankalle

Profile

Date of Birth: 01/02/1952

Qualification: M Sc, Ph D (Biochemistry)

Designation: Senior Scientist

Contacts

e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Phone: Phone: 020-24366920

Research experience: 43 years

Specialization: Virology, Vaccinology, Molecular Evolution/Epidemiology, pathogenesis, biotechnology, epidemiology

Recognized PhD Guide: Savitribai phule pune university(Biotechnology, Microbiology)

Sponsored projects

  • Principal investigator for the project "Attempts to transmit the putative agent to rhesus monkeys" (2011-13)
  • Principal investigator for the project "Attempts to identify the putative Gorakhpur agent using Solid technology" (2011-13)
  • Innate and adaptive immune response in hepatitis E virus infection (2008-12), Co-investigator
  • Principal investigator for the project "A multicentric randomized controlled clinical trial of lamivudine, adefovir plus lamivudine, and combination of glycyrrhizin and adefovir in HBV related decompensated cirrhosis" (2008-12)
  • Principal investigator for the project," Epidemiology of viral hepatitis in tribal populations of India" (2006-2009)
  • Construction of genotype 1 (human)/ genotype 4 (swine) hepatitis E virus chimeras and their characterization in-vivo and in-vitro’, DBT funded (2005-2008), co-investigator.
  • Therapy in patients with chronic hepatitis C: A randomized control trial of interferon with ribavirin and combination of interferon with Glycyrrhizin. (2007-11)
  • Principal Investigator for the project entitled, “Development of liposome-encapsulated recombinant DNA / protein vaccine(s) for H5N1 and other Influenza viruses”
  • Coordinator (Virology) for the ICMR Task Force project entitled, “A multicentric randomized controlled clinical trial of lamivudine, adefovir plus lamivudine, and combination of glycyrrhizin and adefovir in HBV related decompensated cirrhosis
  • Principal investigator for the project entitled, “Genomic characterization of hepatitis E and A viruses in India for 25 years” (2006-09).

Research Programms

The main focus of this group is on childhood immunization and dengue fever

Projects

  • Immune response to childhood vaccinations in Indian preterm infants. PI- DR V Arankalle
  • Prevalence of antibodies against measles, mumps, rubella and varicella in cord blood and toddlers. PI- Nandini Mhase, CO-PI- V. Arankalle, A C Mishra
  • Establishment of a SMART Network System for dengue surveillance in Pune, an initiative for Smart City mission programs. PI- A C Mishra
  • Standardization of Plaque Reduction Neutralization Test for dengue PI-Dr V. Arankalle

Read More

Publications

  • Paingankar MS, Arankalle VA. Identification and characterization of cellular proteins interacting with Hepatitis E virus untranslated regions. Virus Res. 2015; 208:98-109.
  • Joshi SS, Arankalle VA. Enhanced humoral response in pregnant mice immunized with liposome encapsulated recombinant neutralizing epitope protein of Hepatitis- E virus. Virol J. 2015; 12:70.
  • Envelope specific T cell responses & cytokine profiles in chikungunya patients hospitalized with different clinical presentations.
  • Tripathy AS, Tandale BV, Balaji SS, Hundekar SL, Ramdasi AY,Arankalle VA. Indian J Med Res. 2015;141:205-12.
  • Arya RP, Arankalle VA. Toll like receptors in self-recovering hepatitis E patients with or without pregnancy, Human Immunol, 2014, 75:1147-54
  • Haldipur BP, Walimbe AM, Arankalle VA. Circulation of genotype-I hepatitis B virus in the primitive tribes of Arunachal Pradesh in early sixties and molecular evolution of genotype-I. Infect Genet Evol. 2014, 27: 366-74.
  • 7. Ramdasi AY, Arya RP, Arankalle VA. Effect of pregnancy on anti-HEV antibody titres, plasma cytokines and the corresponding gene expression levels in the PBMCs of patients presenting with self-recovering clinical and subclinical hepatitis E. PLoS One. 2014; 9:e103257.
  • Paingankar MS, Arankalle VA. Identification of chikungunya virus interacting proteins in mammalian cells. J Biosci. 2014; 39:389-99.
  • Devhare P, Sharma K, Mhaindarkar V, Arankalle V, Lole K. Virus Res. 2014;184:103-10. Analysis of helicase domain mutations in the hepatitis E virus derived from patients with fulminant hepatic failure: effects on enzymatic activities and virus replication.
  • Rathod SB, Das R, Thanapati S, Arankalle VA, Tripathy AS. Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting hepatitis E.J Viral Hepat. 2014; 21:141-51.
  • Parashar D, Paingankar MS, Kumar S, Gokhale MD, Sudeep AB, Shinde SB, Arankalle VA. Administration of E2 and NS1 siRNAs inhibit chikungunya virus replication in vitro and protects mice infected with the virus. PLoS Negl Trop Dis. 2013;7 :e2405.
  • Devhare PB, Chatterjee SN, Arankalle VA, Lole KS. Analysis of antiviral response in human epithelial cells infected with hepatitis E virus. PLoS One. 2013;8:e63793
  • Deshmukh TM, Shah RR, Gurav YK, Arankalle VA. Serum immunoglobulin G subclass responses in different phases of hepatitis E virus infection. J Med Virol. 2013; 85: 828-32.
  • Das R, Rathod SB, Alagarasu K, Arankalle VA, Tripathy AS. Altered expressions of peripheral CD11c, CD80, CD83 markers and associations of HLA class II allele and haplotypes in self-limiting Hepatitis E infection. Hum Immunol. 2012 13.
  • Mishra N, Walimbe AM, Arankalle VA. Hepatitis E virus from India exhibits significant amino acid mutations in fulminant hepatic failure patients. Virus Genes. 2012 10.
  • Manish Kumar, Sudeep AB, Arankalle VA. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus. Vaccine. 2012 21;30(43):6142-9.
  • Gupte GM, Arankalle VA. Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination. Virol J. 2012 ;9:74.
  • Tripathy AS, Das R, Rathod SB, Arankalle VA. Cytokine Profiles, CTL Response and T Cell Frequencies in the Peripheral Blood of Acute Patients and Individuals Recovered from Hepatitis E Infection. PLoS One. 2012; 7:e31822.
  • Cherian SS, Gunjikar RS, Banerjee A, Kumar S, Arankalle VA. Whole genomes of Chandipura virus isolates and comparative analysis with other rhabdoviruses. PLoS One. 2012;7:e30315.
  • Patil DR, Hundekar SL, Arankalle VA. Expression profile of immune response genes during acute myopathy induced by chikungunya virus in a mouse model. Microbes Infect. 2011.
  • Parashar D, Khalkar P, Arankalle VA. Survival of hepatitis A and E viruses in soil samples. Clin Microbiol Infect. 2011 ;17:E1-4.
  • Mishra N, Arankalle VA. Association of polymorphisms in the promoter regions of TNF-α (-308) with susceptibility to hepatitis E virus and TNF-α (-1031) and IFN-γ (+874) genes with clinical outcome of hepatitis E infection in India. J Hepatol. 2011 ;55(6):1227-34.
  • Tripathy AS, Das R, Rathod SB, Gurav YK, Arankalle VA. Peripheral T regulatory cells and cytokines in hepatitis E infection. Eur J Clin Microbiol Infect Dis. 2011; 31:179-84.
  • Jadi RS, Sudeep AB, Barde PV, Arankalle VA, Mishra AC. Development of an inactivated candidate vaccine against Chandipura virus (Rhabdoviridae: Vesiculovirus). Vaccine. 2011 ;29:4613-7.
  • Arankalle VA, Bandyopadhyay BT, Ramdasi AY, Jadi R, Patil DR, Rahman M, Majumdar M, Banerjee PS, Hati AK, Goswami RP, Neogi DK, Mishra AC. Genomic characterization of Nipah virus, West Bengal, India. Emerg Infect Dis. 2011 ;17:907-9.
  • Sudeep AB, Hundekar SL, Jacob PG, Balasubramanian R, Arankalle VA, Mishra AC. Investigation of a Chikungunya-like illness in Tirunelveli district, Tamil Nadu, India 2009-2010. Trop Med Int Health. 2011
  • Mavale M, Parashar D, Sudeep A, Gokhale M, Ghodke Y, Geevarghese G, Arankalle V, Mishra AC. Venereal transmission of chikungunya virus by Aedes aegypti mosquitoes (Diptera: Culicidae). Am J Trop Med Hyg. 2010; 83: 1242-1244.
  • Arankalle VA, Gandhi S, Lole KS, Chadha MS, Gupte GM, Lokhande MU. An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes. J Viral Hepat. 2010 ;10: 1365-2893.
  • Gurav YK, Tandale BV, Jadi RS, Gunjikar RS, Tikute SS, Jamgaonkar AV, Khadse RK, Jalgaonkar SV, Arankalle VA, Mishra AC. Chandipura virus encephalitis outbreak among children in Nagpur division, Maharashtra, 2007. Indian J Med Res. 2010 ;132:395-399.
  • Arankalle VA, Lole KS, Arya RP, Tripathy AS, Ramdasi AY, Chadha MS, Sangle SA, Kadam DB. Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One. 2010 1;5. 13099.
  • Arankalle VA, Virkar RG, Tandale BV, Ingle NB. Utility of Pandemic H1N1-09 Influenza Virus Recombinant Hemagglutinin Protein Based ELISA for Sero-Surveillance. Clin Vaccine Immunol. 2010.
  • Jadi RS, Sudeep AB, Kumar S, Arankalle VA, Mishra AC. Chandipura virus growth kinetics in vertebrate cell lines, insect cell lines & embryonated eggs. Indian J Med Res. 2010 ;132:155-159.
  • Gupte GM, Ramdasi AY, Kulkarni AS, Arankalle VA. Complete genome sequences of hepatitis C virus subtype 3i and 3a subtype isolates from India Indian J Gastroenterol. 2010;29:101-5.
  • Tripathy AS, Shankarkumar U, Chadha MS, Ghosh K, Arankalle VA. Association of HLA alleles with hepatitis C infection in Maharashtra, western India. Indian J Med Res. 2010;130:550-5.
  • Satyendra Kumar and Vidya A Arankalle. Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis. PloS One, 2010; 5: 8615.
  • Satyendra Kumar and Vidya A Arankalle. Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis. PloS One, 2010; 5: 8615.
  • Venkateswarlu CH, Arankalle VA. Evaluation of the immunogenicity of a recombinant Glycoprotein based Chandipura vaccine in combination with commercially available DPT. Vaccine. 2010 10;28:1463-1467.
  • Verma V, Arankalle VA. Hepatitis E virus-based evaluation of a virion concentration method and detection of enteric viruses in environmental samples by multiplex nested RT-PCR. J Appl Microbiol. 2010 May;108:1630-41
  • ' Faridi MM, Shah N, Ghosh TK, Sankaranarayanan VS, Arankalle V, Aggarwal A, Sathiyasekaran M, Bhattacharya N, Vasanthi T, Chatterjee S, Choudhury J, Mitra M. Immunogenicity and safety of live attenuated hepatitis A vaccine: a multicentric study. Indian Pediatr; 2009: 46;29-34.
  • L.P. Chobe & V.A. Arankalle. Investigation of a hepatitis A outbreak from Shimla, Himachal Pradesh. Indian J Med Res 2009;130:179-84.
  • Shrivastava S, Lole KS, Tripathy AS, Shaligram US, Arankalle VA. Development of candidate combination vaccine for hepatitis E and hepatitis B: A liposome encapsulation approach. Vaccine. 2009 5;27:6582-8
  • Kulkarni MA, Walimbe AM, Cherian S, Arankalle VA. Full length genomes of genotype IIIA Hepatitis A Virus strains (1995-2008) from India and estimates of the evolutionary rates and ages. Infect Genet Evol. 2009 9:1287-94.
  • Tandale BV, Sathe PS, Arankalle VA, Wadia RS, Kulkarni R, Shah SV, Shah SK, Sheth JK, Sudeep AB, Tripathy AS, Mishra AC. Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J Clin Virol., 46:145-9. 2009.
  • Verma V, Arankalle VA. Virological evaluation of domestic water purification devices commonly used in India emphasizes inadequate quality and need for virological standards. Trop Med Int Health. 14:885-91, 2009.
  • Sudeep AB, Parashar D, Jadi RS, Basu A, Mokashi C, Arankalle VA, Mishra AC. Establishment and characterization of a new Aedes aegypti (L.) (Diptera: Culicidae) cell line with special emphasis on virus susceptibility. In Vitro Cell Dev Biol Anim. 2009;45:491-495.
  • Venkateswarlu CH, Arankalle VA. Recombinant glycoprotein based vaccine for Chandipura virus infection. Vaccine. 2009 11;27:2845-50.
  • Saravanabalaji, S. Tripathy, A.S. Dhoot, R.R. Chadha, M.S. Kakrani, A.L. Arankalle, V.A. Viral Load, Antibody Titres and Recombinant Open Reading Frame 2 Protein-Induced Th1/Th2 Cytokines and Cellular Immune Responses in Self-Limiting and Fulminant Hepatitis E. Intervirology 2009; 52: 78-85.
  • Arankalle VA, Ramakrishnan J. Simian hepatitis A virus derived from a captive rhesus monkey in India is similar to the strain isolated from wild African green monkeys in Kenya. J Viral Hepat. 2009; 16: 214-218.
  • Chadha MS, Lole KS, Bora MH, Arankalle VA. Outbreaks of hepatitis A among children in western India. Trans R Soc Trop Med Hyg. 2009 ;103:911-6.
  • Arankalle VA, Lole KS, Deshmukh TM, Srivastava S, Shaligram US. Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Vaccine. 2009 ;27:1032-1039.
  • Cherian SS, Walimbe AM, Jadhav SM, Gandhe SS, Hundekar SL, Mishra AC, Arankalle VA. Evolutionary rates and timescale comparison of Chikungunya viruses inferred from the whole genome/E1 gene with special reference to the 2005-07 outbreak in the Indian subcontinent. Infect Genet Evol.; 9:16-23, 2009
  • -transcriptase PCR for quantitation of Chandipura virus. BMC Infect Dis. 2008 ;8:168.
  • Kulkarni MA and Arankalle VA. Detection and characterization of Hepatitis E virus from pig livers sold in retail markets in India. J Med Virol, 80, 1367, 2008).
  • Tandale BV, Tikute SS, Arankalle VA, Sathe PS, Joshi MV, Ranadive SN, Kanojia PC, Eshwarachary D, Kumarswamy M, Mishra AC. Chandipura virus: a major cause of acute encephalitis in children in North Telangana, Andhra Pradesh, India. J Med Virol. 2008;80:118-24
  • Arankalle V.A., Shrivastava S, Cherian S, Gunjikar R S., Walimbe AM Jadhav SM, Sudeep A, Mishra AC. Genetic Divergence of Chikungunya viruses in India (1963-2006) with special reference to the 2005-06 explosive epidemic. J Gen Virol. 2007; 88: 1967-76.
  • Deshmukh TM, Lole KS, Tripathy AS, Arankalle VA. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Vaccine. 2007 ; 25: 4350-4360.
  • Arankalle VA, Lole KS, Deshmukh TM, Chobe LP, Gandhe SS. Evaluation of human (genotype-1) and swine (genotype-4)-ORF-2 based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type-4 human HEV infections. J Viral Hepat 2007; 14: 435-445.
  • Bondre VP, Jadi RS, Mishra AC, Yergolkar PN, Arankalle VA. West Nile virus isolates from India: evidence for a distinct genetic lineage. J Gen Virol. 2007; 88: 875-84.
  • Prasanna N. Yergolkar, Babasaheb V. Tandale, Vidya A. Arankalle, Padmakar S. Sathe, Sudeep A.B., Swati S. Gandhe, Mangesh D. Gokhle, George P. Jacob, Supriya L. Hundekar, and Akhilesh C. Mishra Chikungunya Outbreaks Caused by African Genotype, India. EID 2006; 12: 1580-1583.
  • Mavale MS, Fulmali PV, Geevarghese G, Arankalle VA, Ghodke YS, Kanojia PC, Mishra AC. Venereal transmission of chandipura virus by phlebotomus papatasi (scopoli). Am J Trop Med Hyg. 2006 ;75:1151-1152.
  • Arankalle VA, Chobe LP, Chadha MS. Type-IV Indian swine HEV infects rhesus monkeys. J Viral Hepat. 2006; 13: 742-745.
  • Arankalle VA, Sarada Devi KL, Lole KS, Shenoy KT, Verma V, Haneephabi M. Molecular characterization of hepatitis A virus from a large outbreak from Kerala, India. Indian J Med Res. 2006; 123: 760-769.
  • Lole KS, Arankalle VA. Quantitation of hepatitis B virus DNA by real-time PCR using internal amplification control and dual TaqMan MGB probes. J Virol Methods. 2006, 135, 83-90.
  • Emerson SU, Clemente-Casares P, Moiduddin N, Arankalle VA, Torian U, Purcell RH. Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. J Gen Virol. 2006; 87:697-704.
  • Chobe LP, Lole KS, Arankalle VA. Full genome sequence and analysis of Indian swine hepatitis E virus isolate of genotype 4. Vet Microbiol. 2006 31;114:240-251.
  • Tripathy A, Balaji S, Rao N, Thakare J, Mishra A, Arankalle V. Cytokine levels in Chandipura virus associated encephalopathy in children. Scand J Infect Dis. 2005; 37: 590-593.
  • Tripathy A, Chadha MS, Arankalle VA. Cytokine profiles in peripheral blood mononuclear cells and sera from patients with acute self-limited hepatitis A. Acta Virol. 2005; 49: 283-284.
  • Chadha MS, Arankalle VA, Jadi RS, Joshi MV, Thakare JP, Mahadev PV, Mishra AC. An outbreak of chandipura virus encephalitis in the eastern districts of gujarat state, India. Am J Trop Med Hyg. 2005;73: 566-570.
  • Emerson SU, Arankalle VA, Purcell RH. Thermal stability of hepatitis E virus. J Infect Dis. 2005 ;192:930-933. 2005.
  • Geevarghese G, Arankalle VA, Jadi R, Kanojia PC, Joshi MV, Mishra AC. Detection of chandipura virus from sand flies in the genus Sergentomyia (Diptera: Phlebotomidae) at Karimnagar District, Andhra Pradesh, India. J Med Entomol. 2005 ; 42: 495-496.
  • Islands, India. Trans R Soc Trop Med Hyg. 2005; 99: 483-484.
  • Arankalle VA, Prabhakar SS, Madhukar WA, Hanumaih, Dattatraya PS, Chandra MA. G, N, and P gene-based analysis of Chandipura viruses, India. Emerg Infect Dis. 2005 ;11: 123-126.
  • Rao BL, Gandhe SS, Pawar SD, Arankalle VA, Shah SC, Kinikar AA. First detection of human metapneumovirus in children with acute respiratory infection in India: a preliminary report. J Clin Microbiol. 2004; 42: 5961-5962.
  • Rao BL, Basu A, Wairagkar NS, Gore MM, Arankalle VA, Thakare JP, Jadi RS, Rao KA, Mishra AC. A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus. Lancet. 2004; 364: 869-874.
  • Arankalle VA. Hepatitis A vaccine strategies and relevance in the present scenario. Editorial, Indian J Med Res, 2004,119.
  • Vaidya SR, Tilekar BN, Walimbe AM, Arankalle VA. Increased risk of hepatitis E in sewage workers from India. J Occup Environ Med. 2003 ; 45 :1167-1170.
  • Lole KS, Jha JA, Shrotri SP, Tandon BN, Prasad VG, Arankalle VA. Comparison of hepatitis C virus genotyping by 5' noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol. 2003 ; 41 :5240-5244.
  • Lole KS, Jha JA, Shrotri SP, Tandon BN, Prasad VG, Arankalle VA. Comparison of hepatitis C virus genotyping by 5' noncoding region- and core-based reverse transcriptase PCR assay with sequencing and use of the assay for determining subtype distribution in India. J Clin Microbiol. 2003 ; 41 :5240-5244.
  • Arankalle VA, Murhekar KM, Gandhe SS, Murhekar MV, Ramdasi AY, Padbidri VS, Sehgal SC. Hepatitis B virus: predominance of genotype D in primitive tribes of the Andaman and Nicobar islands, India (1989-1999). J Gen Virol. 2003 ;84 :1915-1920.
  • Arankalle VA, Chadha MS. Who should receive hepatitis A vaccine? J Viral Hepat. 2003; 10 :157-158.
  • Chadha MS, Walimbe AM, Chobe LP, Arankalle VA. Comparison of etiology of sporadic acute and fulminant viral hepatitis in hospitalized patients in Pune, India during 1978-81 and 1994-97. Indian J Gastroenterol. 2003 ; 22:11-15.
  • Arankalle VA, Chobe LP, Walimbe AM, Yergolkar PN, Jacob GP. Swine HEV infection in south India and phylogenetic analysis (1985-1999). J Med Virol. 2003 ; 69 :391-396.
  • Gandhe SS, Chadha MS, Arankalle VA. Hepatitis B virus genotypes and serotypes in western India: Lack of clinical significance. J Med Virol. 2003 ;69: 324-330.
  • Risbud A, Mehendale S, Basu S, Kulkarni S, Walimbe, Arankalle V, Gangakhedkar R, Divekar A, Bollinger R, Gadkari D and Paranjape R. Prevalence & Incidence of Hepatitis B virus infection in STD clinic attendees in Pune, India, Sexually Transmitted Infections, 2002, 78; 169-173.
  • Murhekar M, Murhekar K, Arankalle V, Sehgal S. Immune response to an indigenously developed hepatitis-B (Shanvac-B) vaccine in a tribal community of India. Vaccine. 2002 ;20, :3431-3435.
  • Renge RL, Dani VS, Chitambar SD, Arankalle VA. Related. Vertical transmission of hepatitis A. Indian J Pediatr. 2002 ;69 :535-536.
  • Murhekar MV, Murhekar KM, Arankalle VA, Sehgal SC. Epidemiology of hepatitis B infection among the Nicobarese--a mongoloid tribe of the Andaman and Nicobar Islands, India. Epidemiol Infect. 2002; 128: 465-471.
  • Joshi MS, Chitambar SD, Arankalle VA, Chadha MS. Evaluation of urine as a clinical specimen for diagnosis of hepatitis A. Clin and Diag Lab Immunol, 9; 840-845, 2002.
  • Murhekar MV, Sehgal SC, Murhekar KM, Padbidri VS, Chitambar SD, Arankalle VA. Changing scenario of HAV and HEV exposure among the primitive tribes of Andaman and Nicobar islands, India over a ten year period (1989-1999). J Viral Hepat. 2002 ; (4):315-21.
  • Vaidya SR, Chitambar SD, Arankalle VA. PCR-based Prevalence of Hepatitis A, Hepatitis E and TT Viruses in Sewage from an endemic area. J Hepatol, 2002; 37:131-6.
  • Joshi MS, Walimbe AM, Arankalle VA, Chadha MS, Chitambar SD. Hepatitis E antibody profiles in serum and urine. J Clin Lab Anal, 16, 137-42, 2002.
  • Renge RL, Dani VS, Chitambar SD, Arankalle VA. Fulminant hepatitis A in children with sickle cell disease. Ind Pediatr, 39, 186-189, 2002.
  • Arankalle VA, Chobe LP, Joshi MV, Kundu B, Walimbe AM. Human and Swine Hepatitis E Viruses from India Belong to Different Genotypes. J Hepatol, 36,417-425, 2002.
  • Arankalle VA, Chadha MS, Chitambar SD, Walimbe AM, Chobe LP and Gandhe SS. Changing epidemiology of Hepatitis A and Hepatitis E in urban and rural India (1982-1998). J Viral Hepat, 8, 293-303, 2001.
  • Arankalle, V. A., Joshi, M. V., Kulkarni, A. M., Gandhe, S. S., Chobe, L. P., Rautmare, S. S., Mishra, A. C., Padbidri, V. S. Prevalence of anti-HEV antibodies in different Indian animal species. J Viral Hepat, 8, 223-227, 2001.
  • Chitambar SD, Joshi MS, Sreenivasan MA, Arankalle VA. Fecal shedding of hepatitis A virus in Indian patients with hepatitis A and in experimentally infected rhesus monkey. Hepatol Res,19:237-246, 2001
  • Arankalle VA, Deshmukh TM, Chobe LP, Chadha MS, Walimbe AM.Prevalence of HGV RNA in India and phylogenetic analysis based on 5' non-coding region, Ind J Gastroenterol ; 20, 13-7 2001.
  • Arankalle VA, Gandhe SS, Deshmukh TM, Chadha MS, Walimbe AM. Prevalence and phylogenetic analysis of Transfusion Transmitted Virus DNA among Indian patients. Clin and Diag Lab Immunol, 2000 ; 7 : 845-9.
  • Murhekar MV, Murhekar KM, Das D, Arankalle VA, Sehgal SC. Prevalence of Hepatitis B Virus infection among the primitive tribes of Andaman and Nicobar islands: A preliminary report. Ind J Med Res. 2000 ; 111 : 199-203.
  • Chadha MS and Arankalle VA. Ten year serological follow up of hepatitis B vaccine recipients in India. Ind J Gastroenterol. 2000 ; 19 : 168-71.
  • Arankalle VA Current blood transfusion practices in India. Editorial, Ind J Gastroenterol, 19,1, 2000.
  • Goyal R, Arankalle VA, Bhave S. Fulminant hepatic failure. Indian Pediatr ; 37 : 454. 2000.
  • Arankalle VA and Chobe LP Retrospective analysis of blood transfusion recipients: Evidence for post-transfusion hepatitis E. Vox Sang, 79 : 72-4, 2000.
  • Arankalle VA, Chadha MS, Mehendale SM, Tungatkar SP. Lack of intrafamilial spread of hepatitis E: Observations during epidemics of the disease. Ind J Gastroenterol, 19, 24-28, 2000.
  • Chadha MS, Walimbe AM, Arankalle VA. Retrospective serological analysis of hepatitis E patients: A long term follow up study. J. Viral hepatitis, 6, 457-461,1999.
  • Bendre SV, Bavdekar AR, Bhave SV, Pandit AN, Chitambar SD, Arankalle VA. Fulminant hepatic Failure in children - Etiology, viral markers and outcome. Ind. Pediatrics, 36,1107-12, 1999.
  • Arankalle VA, Paranjape S, Emerson SU, Purcell RH, Walimbe AM. Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993). J Gen Virol. 80, 1691-1700, 1999.
  • Chadha MS, Chitamber SD, Sheikh NJ, Arankalle VA. Exposure of Indian children to HAV and vaccination age. Ind J Med Res 109: 11-15,1999.
  • Chadha MS, Tungatkar SP, Arankalle VA. Insignificant prevalence of antibodies to hepatitis C in a rural area of western Maharashtra. Ind J Gastroenterol 18: 22-23, 1999.
  • Arankalle VA, Chobe LP. Hepatitis E virus: Can it be transmitted parenterally? J Viral Hepatitis 6: 161-164, 1999.
  • Arankalle VA, Chadha MS, Chobe LP. Long term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus. J Hepatology. 30: 199-204, 1999.
  • Chitambar SD, Chadha MS, Joshi MS, Arankalle VA. Prevalence of hepatitis A antibodies in western Indian population: Changing pattern. Southeast Asian J Trop Med public health, 109, 11-15,1999.
  • Arankalle VA, Chadha MS, Dama BN, Tsarev SA, Purcell RH, Banerjee K. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J. Viral Hepatitis, 5: 199-204, 1998.
  • Tungatkar SP, Divekar AD, Arankalle VA. Exposure of STD patients and prisoners from Pune to hepatitis B and C viruses. Ind J Med Microbiol 15 117, 1997.
  • Chobe LP, .Chadha MS, Banerjee K , Arankalle VA. Detection of HEV-RNA by RT-PCR during the epidemics of hepatitis E. J Viral Hepatitis, 4: 129-133, 1997.
  • Chitambar SD, Joshi MS, Arankalle VA, Banerjee K. Sensitive ELISAs for detection of anti-hepatitis A virus antibodies. Serodiagnosis and Immunotherapy, 8 : 63-65, 1996.
  • Chitambar SD, Chadha MS, Yeolekar LR, Arankalle VA. Hepatitis A in Day Care Centre. Ind.J.Pediatr. 63: 781-783, 1996.
  • Jha J, Banerjee K, Arankalle VA. A high prevalence of antibodies to hepatitis C virus among commercial plasma donors from Western India. J.Viral Hepatitis.2, 251-254, 1995.
  • Jha J, Banerjee K, Arankalle VA. Hepatitis C virus RNA positivity among RIBA-3 indeterminates. Vox Sang. 69, 145, 1995.
  • es of hepatitis E virus. J.Med.Virol. 46, 358, 1995.
  • Arankalle VA, Jha J, Favorov MO, Chaudhari A, Fields HA, Banerjee K. Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in Western India. J.Viral.Hepatitis. 2:189 193, 1995.
  • Arankalle VA, Chadha MS, Jha J,.Amrapurkar DN, Banerjee K. Prevalence of anti-HCV antibodies in Western India. Ind.J.Med.Res. 101, 91, 1995.
  • Arankalle VA,.Tungatkar SP, Banerjee K. Anti-HCV positivity among blood donor population from Pune, India (1981-1994). Vox Sang., 69, 75, 1995.
  • Arankalle VA and K.Banerjee K. Prior hepatitis A virus infection does not enhance acute hepatitis E infection. Medical Hypothesis, 44: 227-228, 1995.
  • Arankalle VA, Tsarev SA, Chadha MS,.Aling DW, Emerson SU, Banerjee K, Purcell RH. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J.Infect.Dis. 171, 447, 1995.
  • Arankalle VA, Goverdhan MK, Banerjee K. Antibodies against hepatitis E virus in old world monkeys. J.Viral.Hepatitis 1: 125-129, 1994.
  • Arankalle VA, Chadha MS, Tsarev SA, Emerson SU, Risbud AR, Banerjee K, Purcell RH. Seroepidemiology of water-borne hepatitis in India and evidence for a new enterically transmitted hepatitis agent. Proc.Natl.Acad.Sci. 91:3428-3432, 1994.
  • Sreenivasan MA, Pant U, Athawale SS, Arankalle VA. Detection by electron microscopy of endogenous viruses in Aedes krowleini(H) cell line. In vitro 30A: 142-143, 1994.
  • Chitambar SD, Grewal SM,.Bokil M, Arankalle VA, Gore MM, Banerjee K. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis. Ind.J.Med.Res. 99: 243-248, 1994.
  • Arankalle VA, Sreenivasan MA, Andjaparidze AG,.Balayan MS. Enterically transmitted non-A, non-B hepatitis viruses from India and USSR : a comparative study. Ind.J.Virol. 9: 107-110, 1993.
  • Arankalle VA, Favorov MO, Chadha MS, Phule DM, Banerjee K. Rhesus monkeys infected with hepatitis E virus from the former USSR are immune to subsequent challenge with an Indian strain. Acta Virol. 37, 515-518, 1993.
  • Arankalle VA, Chadha MS, Banerjee K,.Srinivasan MA, Chobe LP. Hepatitis E virus infection in pregnant rhesus monkeys. Ind.J.Med.Res. 97\: 4-8, 1993.
  • Chadha MS, Arankalle VA, J, Banerjee K. Prevalence of hepatitis B and C virus infections among haemodialysis patients in Pune (Western India). Vox Sang, 64, 127-128, 1993.
  • Arankalle VA, Chobe LP, Jha J, Chadha MS, Banerjee K, Favorov MO., Kalinina T, Fields HA. Aetiology of acute sporadic non-A, non-B hepatitis in Western India. J.Med.Virol. 40: 121-125, 1993.
  • Arankalle VA,.Ramamoorthy CL, Banerjee K. Seroepidemiology of hepatitis delta virus infection in Pune, India. Trans.Roy.Soc.Trop.Med.Hyg. 86, 89, 1992.
  • Arankalle VA, Chobe LP, Banerjee K. Hepatitis C virus in Pune, India. JAPI, 40, 562, 1992.
  • Chadha MS, Arankalle VA, Banerjee K. Comparative immunogenicity of hepatitis B vaccines in various risk groups in India. JAPI, 40: 584-588, 1992.
  • Risbud AR, Chadha MS, .Kushwah SS, Arankalle VA,.Rodrigues FM, Banerjee K. Non-A, Non-B hepatitis epidemic in Rewa district of Madhya Pradesh. JAPI, 40: 262-266, 1992.
  • Chadha MS,.Mehandale SM, Arankalle VA,.Athley NK, Banerjee K. Water supply schemes and enterically transmitted non-A, non-B hepatitis epidemics : An experience in Khadakwasla village of Pune District. Ind.J.Comm.Med. 16: 153-158, 1991.
  • Chitambar SD, Arankalle VA, Banerjee K. Detection of IgM against hepatitis A virus using tissue culture derived antigen. Ind.J.Med.Res. 93: 19-23, 1991.
  • Chobe LP, Chadha MS, Arankalle VA,Gogate SS, Banerjee K. Hepatitis B infection among dental personnel in India. Ind.J.Med.Res. 93: 143-146, 1991.
  • Arankalle VA, Sehgal A, Banerjee K. Hepatitis B seromarkers among medical paramedical personnel. JAPI, 39, 293, 1991.
  • Chadha MS, Arankalle VA, Banerjee K. Follow up of cases of enterically transmitted non-A, non-B hepatitis. JAPI, 3: 651, 1991.
  • Arankalle VA, Chadha MS, Banerjee K. Necessity to vaccinate spouses of hepatitis B patients and carriers. JAPI, 38: 577, 1990.
  • Israel ZR, Bose M, Rodrigues JJ, Arankalle VA, Athalye NK, Pavri KM. Absence of antibodies to HIV in health workers after hepatitis B vaccination. JAPI 36, 179, 1988.
  • Chadha MS, Risbud AR, Arankalle VA, Chobe LP,.Rasheed MA,.Rodrigues FM, Banerjee K. Enterically transmitted non-A non-B hepatitis : First report of an outbreak in an isolated population. Ind.J.Med.Microbiol. 6: 289-293, 1988.
  • Arankalle VA, Chadha MS, Chobe LP. Regular follow-up of chronic HBsAg carriers found Vox Sang 55, 50, 1988.
  • Arankalle VA, Ramamoorthy CL, Dhorje SP, Pavri KM. Anti-delta antibodies in commercial immunoglobulin preparations. Ind.J.Med.Res. 87: 194-197, 1988
  • Arankalle VA, Chadha MS, Mehendale SM, Banerjee K. Outbreak of enterically transmitted non-A non-B hepatitis among school children. Lancet 1988; 2: 1199-1200.
  • Arankalle VA and Banerjee K. Viruses of enterically transmitted non-A non-B hepatitis. Lancet 1988; 2: 160.
  • Arankalle VA, Ticehurst JT, Sreenivasan MA, Kapikian AZ, Popper H, Pavri KM, Purcell RH. Etiologic association of a virus-like particle with enterically transmitted non-A non-B hepatitis. Lancet 1988; 1: 550-554.
  • Sehgal A, Pavri KM, Arankalle VA, Jhala CI, Dhorje SP, Ramamoorthy CL. Antibody response to hepatitis B vaccine in medical and paramedical personnel in India. Ind.J.Med.Res. 858, 231-234, 1887.
  • Sehgal A, Arankalle VA,.Dhorje SP, Ramamoorthy CL, Phule DM, Pavri KM. Diagnostic significance of anti-HBc-IgM in patients of acute viral hepatitis. Ind.J.Med.Res. 83, 547-550, 1986.
  • Sreenivasan MA, Arankalle VA, Sehgal A, Pavri KM. Non-A, Non-B hepatitis: Visualisation of virus-like particles in the stool by immune electron microscopy. J.Gen.Virol. 65, 1005-1008, 1984.
  • Sehgal A, Arankalle VA, Gadkari DA, Pavri KM. Hepatitis B infection in an Orphanage. Ind.J.Med.Res. 78: 607-610, 1983.
  • Baride RM, Jain SD, Gaitonde BB. Immunological and biochemical studies on the formalised toxoid of red scorpion venom. Ind.J.Med.Res. 73, 122-125, 1981.
  • Gaitonde BB and. Baride RM. Toxoidation of venoms of poisonous Indian snakes. Ind.J.Med.Res. 73, 115-121, 1981.
  • Baride RM, Jain SD, Gaitonde BB. Biochemical studies on the toxids of venoms of poisonous Indian snakes. Ind.J.Med.Res. 72, 571-576, 1980.
  • Baride RM and Gaitonde BB. Biochemical changes in experimental rabies: Brain monomines and free amino acid. Ind.J.Med.Res. 72, 475-479, 1980.
  • Baride RM and Gaitonde BB. Effect of prior immunisation and subsequent challenge with rabies virus in mice. Ind.J.Med.Res. 71, 833-839, 1980.

Chapters in Books:

  • Arankalle VA, Chadha MS, Favorov MO, Tsarev SA, Emerson SU, Fields HA, Purcell RH, Banerjee K. 1995 Aetiology of acute sporadic non-A,non-B viral hepatitis in India. Frontiers in Virology: Diagnosis of human viruses by polymerase chain reaction, chapter 16, Ed. Darai. Springer-Verlag Press, pp.123-134.
  • Arankalle VA. 1996 Hepatitis B vaccination: Indian experience. In "HepatitisB in India. Problems and prevention" Eds. Sarin SK and Singhal AK, CBS Publishers and Distributors. pp.152-164.
  • Arankalle VA. 1997 Epidemiology of HCV infection in India:Community Acquired v/s post-transfusion. In "Transfusion Associated Hepatitis",Eds. S.K.Sarin and Hess G., CBS Publishers and Distributors. pp.113-133.
  • Arankalle VA. 2000 Epidemiology of HCV in India: A comprehensive critical analysis. In "Hepatitis B and C: carrier to cancer " eds S.K Sarin and K Okuda, Springer-Verlog Singapore publishers,
  • Arankalle VA. 2008 Hepatitis Viruses: Virology and Epidemiology. Tropical Hepatogastroenterology, chapter 14:261-268, Editor Dr B N Tandon, Elsevier publications.
  • Arankalle VA, Gandhe SS. 2008 Virological diagnosis of hepatitis. Tropical Hepatogastroenterology, Chapter 15:269-276, Editor Dr B N Tandon, Elsevier publications.
  • Arankalle VA. Hepatitis E in India; For NASI publication; In press
  • Arankalle VA. 1995 Development and evaluation of serodiagnosis of HEV. Hepatitis E Virus: Epidemiology to Vaccine development. Eds Drs B N Tandon& S K Acharya. Tropical Gastroenterology publication. Pp 77-80.
  • Arankalle VA, 2006 HEV infection-Probably a Zoonosis in "Trends and Research in Viral hepatitis", Sir Dorabji Tata Symposium Series, Eds D Raghunath, R Nayak, PP 359-369
  • Arankalle VA and Prasanna Yergolkar, 2008 Chikungunya outbreaks in Karnataka and bordering states in southern India, in "Arthropod Borne Viral Infections: Current status and Research", Sir Dorabji Tata Symposium Series, Eds D Raghunath, C Durga Rao, PP 359-369.
  • Arankalle VA. 2004. Viral Hepatitis. Golden Jubilee Publication; NIV Commemorative Compendium, Ed. A C Mishra, PP 53-200.
  • Arankalle VA. 2011. "Hepatitis E in India".Pproceedings of the National Academy of Sciences India, Elsevier publications.